Thromb Haemost 1977; 38(01): 255
DOI: 10.1055/s-0039-1680764
Supplemental Abstracts
Schattauer GmbH

The Isolation of a Potent Plasma Kallikrein with Weak Plasminogen Activator Activity

M.J. Gallimore
1   Institute for Surgical Research, Institute for Thrombosis Research, Rikshospitalet, Oslo, Norway
,
E. Fareid
1   Institute for Surgical Research, Institute for Thrombosis Research, Rikshospitalet, Oslo, Norway
,
H. Stormorken
1   Institute for Surgical Research, Institute for Thrombosis Research, Rikshospitalet, Oslo, Norway
› Author Affiliations
Further Information

Publication History

Publication Date:
16 April 2019 (online)

 

    Kallikrein was isolated from human plasma by the following procedures: removal of euglobulins at pH 5.3; QAE Sephadex chromatography: gel filtration on Sephadex G-150 and G-100. The partially purified preparation was then freed of contaminants by running it down a column of Sepharose-4B to which had been linked antibodies to IgG and pre-PTA. Pre-kallikrein and kallikrein activities were monitored during the fractionation procedures using a new synthetic chromogenic substrate for plasma kallikrein (Chromozyme-PK, Penta-pharm, Basle, Switzerland). 5 mg of enzyme was obtained with a specific activity of 3.75 Chromozyme PK (CPK) units/mg at 22° (yield = 9.5%: purification factor = 6250) and the yield of kinin from heated plasma was 1.79 μg/CPK unit/min. The kallikrein exhibited very weak plasminogen activator activity when tested on fibrin plates and in fibrin clot lysis assays(1 CPK unit =0.133 CTA units urokinase). Some other properties of the enzyme are discussed.


    #

     


    #